Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 2Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 7Thoracic 2Gastrointestinal 2Lymphoid 1Breast 1

Conditions

Smoking Cessation 1Lung Neoplasms 1Lung Cancer Prevention 1

Interventions

Carboplatin 551Pemetrexed 404Cisplatin 401Paclitaxel 273Docetaxel 255Gemcitabine 218pembrolizumab 191Bevacizumab 190Erlotinib Hydrochloride 184Radiotherapy 181Etoposide 147durvalumab 140Nivolumab 134Drug Therapy 127osimertinib 107atezolizumab 92Gefitinib 74Radiosurgery 72anlotinib 69Vinorelbine 68tislelizumab 52Irinotecan 51Ipilimumab 50130-nm albumin-bound paclitaxel 50Taxes 48Surgical Procedures, Operative 46Cetuximab 46sintilimab 45Albumin-Bound Paclitaxel 45apatinib 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Tea × Thoracic × Clear all
NCT02719860 2016-03-25

High Tea Consumption on Smoking Related Oxidative Stress

University of Arizona

Phase 2 Completed
154 enrolled
Thoracic

Lung Cancer Prevention

NCT00363805 2013-11-28

Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease

University of Arizona

Phase 2 Completed
178 enrolled 10 charts
Thoracic

Lung Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡